BioSolution Co., Ltd. has developed a safety/efficacy evaluation test method based on a human tissue model, and the skin model (KeraSkin™) and cornea model (MCTT HCE™) are listed in the OECD toxicity evaluation guidelines. In particular, the 'Skin Irritation Test Method for Medical Devices Using Human Skin Model (KeraSkin™) (ISO 10993-23:2021)' has been approved as an international standard test method by the International Organization for Standardization (ISO). In addition, we have obtained GLP (Good Laboratory Practice) certification from the Ministry of Food and Drug Safety for skin irritation and eye irritation testing. Biosolution Co., Ltd. sells various human tissue models, and provides prompt and accurate non-clinical and efficacy evaluation test services using human tissue models developed by Biosolution Co., Ltd. with a value for reliability, which is the core of GLP.
moreEXHIBIT
COMPANY INTRODUCTION
BioSolution Co., Ltd. has developed a safety/efficacy evaluation test method based on a human tissue model, and the skin model (KeraSkin™) and cornea model (MCTT HCE™) are listed in the OECD toxicity evaluation guidelines. In particular, the 'Skin Irritation Test Method for Medical Devices Using Human Skin Model (KeraSkin™) (ISO 10993-23:2021)' has been approved as an international standard test method by the International Organization for Standardization (ISO). In addition, we have obtained GLP (Good Laboratory Practice) certification from the Ministry of Food and Drug Safety for skin irritation and eye irritation testing. Biosolution Co., Ltd. sells various human tissue models, and provides prompt and accurate non-clinical and efficacy evaluation test services using human tissue models developed by Biosolution Co., Ltd. with a value for reliability, which is the core of GLP.
